Long-term outcome following radical prostatectomy for Gleason 8–10 prostatic adenocarcinoma

World Journal of Urology

Volumn 32, Issue 6, 2014, Pages 1385-1392

  Pokala, Naveen ^a   Trulson, Jerry J ^a   Islam, Majdee ^a  

^a University of Missouri   (United States)

Author keywords

Prostatic neoplasm surgery; Prostatic neoplasms pathology; SEER database; Survival analysis; Treatment outcome

Indexed keywords

ADENOCARCINOMA; AGED; CANCER GRADING; COHORT ANALYSIS; DISEASE FREE SURVIVAL; HUMAN; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; COHORT STUDIES; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84912047642     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-014-1253-1     Document Type: Article

References (28)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10–29
2. Epstein JI, Carmichael MJ, Pizov G et al (1993) Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term follow-up. J Urol 150(1):135–141
3. Sgrignoli AR, Walsh PC, Steinberg GD et al (1994) Prognostic factors in men with stage D1 prostate cancer: identification of patients less likely to have prolonged survival after radical prostatectomy. J Urol 152:1077–1081
4. Albertsen PC, Hanley JA, Gleason DF et al (1998) Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 280:975
5. Hull GW, Rabbani F, Abbas F et al (2002) Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 167:528
6. Sweat SD, Bergstralh EJ, Slezak J, Blute ML, Zincke H (2002) Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age. J Urol 168:525–529
7. Paulson DF, Piserchia PV, Gardner W (1980) Predictors of lymphatic spread in prostatic adenocarcinoma: uro-oncology research group study. J Urol 123:697
8. Sogani PC, Israel A, Lieberman PH et al (1985) Gleason grading of prostate cancer: a predictor of survival. Urology 25:223
9. Meng MV, Elkin EP, Latini DM, Duchane J, Carroll PR (2005) Treatment of patients with high risk localized prostate cancer: results from cancer of the prostate strategic urological research endeavor (CaPSURE). J Urol 173:1557–1561
10. Manoharan M, Bird VG, Kim SS, Civantos F, Soloway MS (2003) Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of ≥8. BJU Int 92:539–544
11. Boorjian SA, Karnes RJ, Crispen PL, Rangel LJ, Bergstralh EJ, Sebo TJ et al (2009) The impact of discordance between biopsy and pathological Gleason scores on survival after radical prostatectomy. J Urol 181:95–104
12. Donohue J, Bianco F, Kuroiwa K et al (2006) Poorly differentiated prostate cancer treated with radical prostatectomy: long term outcome and incidence of pathological downgrading. J Urol 176(3):991–995
13. Bill-Axelson A, Holmberg L, Ruutu M, Haggman M, Andersson SO, Bratell S et al (2011) Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 364:1708–1717
14. Tewari A, Divine G, Chang P et al (2007) Long-term survival in men with high grade prostate cancer: a comparison between conservative treatment, radiation therapy and radical prostatectomy—a propensity scoring approach. J Urol 177(3):911–915
15. Shao YH, Kim S, Moore D et al (2013) Cancer-specific survival after metastasis following primary radical prostatectomy compared with radiation therapy in prostate cancer patients: results of a population-based, propensity score–matched analysis. Eur Urol. Online 21 May 2013. ISSN 0302-2838. doi:10.1016/j.eururo.2013.05.023
16. Mian BM, Troncoso P, Okihara K et al (2002) Outcome of patients with Gleason score 8 or higher prostate cancer following radical prostatectomy alone. J Urol 167:1675–1680
17. Lughezzani G, Gallina A, Larcher A et al (2013) Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer. BJU Int 111(5):723–730
18. Gerber GS, Thisted RA, Scardino PT et al (1996) Results of radical prostatectomy in men with clinically localized prostate cancer. JAMA 276:615
19. Grossfeld GD, Chang JJ, Broering JM et al (2000) Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database. J Urol 163:1171–1177
20. Boorijan SA, Thompson RH, Siddiqui S et al (2007) Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. J Urol 178(3):864–870
21. Brimo F, Partin AW, Epstein JI (2010) Tumor grade at margins of resection in radical prostatectomy is an independent predictor of prognosis. Urology 76(5):1206–1209
22. Pierorazio PM, Ross AE, Schaeffer EM et al (2011) A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomy. J Urol 185(5):1691–1697
23. Hubanks M, Boorjian SA, Frank I et al (2013) The presence of extracapsular extension is associated with an increased risk of death from prostate cancer after radical prostatectomy for patients with seminal vesicle invasion and negative lymph nodes. Urol Oncol. Online 6 February 2013. ISSN 1078-1439. doi:10.1016/j.urolonc.2012.09.002
24. Lau WK, Bergstralh EJ, Blute ML, Slezak JM, Zincke H (2002) Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: influence of concomitant pathological variables. J Urol 167:117
25. 11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms. Eur Urol 54(2):392–401
26. Cheng L, Zincke H, Blude M et al (2001) Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 91(1):66–73
27. Briganti A, Karnes J, Filippo Da Pozzo L et al (2009) Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy. Eur Urol 55(2):261–270
28. Daneshmand S, Quek M, Stein J et al (2004) Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long term results. J Urol 172(6):2252–2255